Bladder cancer
O Sanli, J Dobruch, MA Knowles, M Burger… - Nature reviews Disease …, 2017 - nature.com
Bladder cancer is a highly prevalent disease and is associated with substantial morbidity,
mortality and cost. Environmental or occupational exposures to carcinogens, especially …
mortality and cost. Environmental or occupational exposures to carcinogens, especially …
The burden of bladder cancer care: direct and indirect costs
M Mossanen, JL Gore - Current opinion in urology, 2014 - journals.lww.com
The burden of bladder cancer care: direct and indirect costs : Current Opinion in Urology The
burden of bladder cancer care: direct and indirect costs : Current Opinion in Urology Log in or …
burden of bladder cancer care: direct and indirect costs : Current Opinion in Urology Log in or …
Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline
SS Chang, BH Bochner, R Chou, R Dreicer… - The Journal of …, 2017 - auajournals.org
Purpose: This multidisciplinary, evidence-based guideline for clinically non-metastatic
muscle-invasive bladder cancer focuses on the evaluation, treatment and surveillance of …
muscle-invasive bladder cancer focuses on the evaluation, treatment and surveillance of …
Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer
JA Witjes, T Lebret, EM Compérat, NC Cowan… - European urology, 2017 - Elsevier
Context Invasive bladder cancer is a frequently occurring disease with a high mortality rate
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and …
despite optimal treatment. The European Association of Urology (EAU) Muscle-invasive and …
Robot-assisted radical cystectomy versus open radical cystectomy in bladder cancer patients: a multicentre comparative effectiveness study
CJ Wijburg, CTJ Michels, G Hannink, JPC Grutters… - European Urology, 2021 - Elsevier
Background Radical cystectomy with pelvic lymph node dissection (PLND) and urinary
diversion in patients with bladder cancer is known for its high risk of complications. Although …
diversion in patients with bladder cancer is known for its high risk of complications. Although …
Quality of life after radical cystectomy
MD Tyson, DA Barocas - Urologic Clinics, 2018 - urologic.theclinics.com
Bladder cancer is the second most common genitourinary malignancy in the United States
with an estimated incidence of approximately 11.6 cases per 100,000 per year. 1 …
with an estimated incidence of approximately 11.6 cases per 100,000 per year. 1 …
Sexual dysfunction after cystectomy and urinary diversion
RA Modh, JP Mulhall, SM Gilbert - Nature Reviews Urology, 2014 - nature.com
Erectile dysfunction (ED) in men and sexual dysfunction in men and women are common
after cystectomy and urinary diversion. Research has focused on both qualifying the …
after cystectomy and urinary diversion. Research has focused on both qualifying the …
Health-related quality of life after treatment for bladder cancer in England
SJ Mason, A Downing, P Wright, L Hounsome… - British Journal of …, 2018 - nature.com
Background Little is known about quality of life after bladder cancer treatment. This common
cancer is managed using treatments that can affect urinary, sexual and bowel function …
cancer is managed using treatments that can affect urinary, sexual and bowel function …
Urinary functional outcome following radical cystoprostatectomy and ileal neobladder reconstruction in male patients
H Ahmadi, EC Skinner, V Simma-Chiang… - The Journal of …, 2013 - auajournals.org
Purpose: Orthotopic neobladder reconstruction is the preferred method of urinary diversion
after radical cystoprostatectomy. We evaluated urinary functional outcomes in male patients …
after radical cystoprostatectomy. We evaluated urinary functional outcomes in male patients …
[HTML][HTML] Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer
MD Galsky, AV Balar, PC Black… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
A number of immunotherapies have been developed and adopted for the treatment of
urothelial cancer (encompassing cancers arising from the bladder, urethra, or renal pelvis) …
urothelial cancer (encompassing cancers arising from the bladder, urethra, or renal pelvis) …